-
1
-
-
0031013422
-
-
and ref. cit. therein
-
B.L. Iverson, Nature (London) 1997, 385, 113; and ref. cit. therein.
-
(1997)
Nature (London)
, vol.385
, pp. 113
-
-
Iverson, B.L.1
-
2
-
-
0029953285
-
-
D. Seebach, M. Overhand, F.N.M. Kühnle, B. Martinoni, L. Oberer, U. Hommel, H. Widmer, Helv. Chim. Acta 1996, 79, 913; D. Seebach, P.E. Ciceri, M. Overhand, B. Jaun, D. Rigo, L. Oberer, U. Hommel, R. Amstutz, H. Widmer, ibid. 1996, 79,2043.
-
(1996)
Helv. Chim. Acta
, vol.79
, pp. 913
-
-
Seebach, D.1
Overhand, M.2
Kühnle, F.N.M.3
Martinoni, B.4
Oberer, L.5
Hommel, U.6
Widmer, H.7
-
3
-
-
0029856721
-
-
D. Seebach, M. Overhand, F.N.M. Kühnle, B. Martinoni, L. Oberer, U. Hommel, H. Widmer, Helv. Chim. Acta 1996, 79, 913; D. Seebach, P.E. Ciceri, M. Overhand, B. Jaun, D. Rigo, L. Oberer, U. Hommel, R. Amstutz, H. Widmer, ibid. 1996, 79,2043.
-
(1996)
Helv. Chim. Acta
, vol.79
, pp. 2043
-
-
Seebach, D.1
Ciceri, P.E.2
Overhand, M.3
Jaun, B.4
Rigo, D.5
Oberer, L.6
Hommel, U.7
Amstutz, R.8
Widmer, H.9
-
6
-
-
0029930278
-
-
For the most recent extensive coverage of this methodology see a Tetrahedron issue (Symposium-in-print No. 63) and two articles: Tetrahedron 1996, 52, 4527-4554; ibid. 1997, 53, 5643-5678 and 6573-6705.
-
(1996)
Tetrahedron
, vol.52
, pp. 4527-4554
-
-
-
7
-
-
0031001699
-
-
For the most recent extensive coverage of this methodology see a Tetrahedron issue (Symposium-in-print No. 63) and two articles: Tetrahedron 1996, 52, 4527-4554; ibid. 1997, 53, 5643-5678 and 6573-6705.
-
(1997)
Tetrahedron
, vol.53
, pp. 5643-5678
-
-
-
8
-
-
0000686498
-
-
Cf. the homologative peptide coupling: J. Podlech, D. Seebach, Angew. Chem. 1995, 107, 507; ibid. Int. Ed. 1995, 34, 471.
-
(1995)
Angew. Chem.
, vol.107
, pp. 507
-
-
Podlech, J.1
Seebach, D.2
-
9
-
-
0040598317
-
-
ibid
-
Cf. the homologative peptide coupling: J. Podlech, D. Seebach, Angew. Chem. 1995, 107, 507; ibid. Int. Ed. 1995, 34, 471.
-
(1995)
Int. Ed.
, vol.34
, pp. 471
-
-
-
10
-
-
77950917295
-
-
East Hanover, USA, is gratefully acknowledged (R.E. Marti, K.H. Bleicher, K.W. Bair)
-
Personal communication of independent work along these lines by researchers of Novartis Pharma, East Hanover, USA, is gratefully acknowledged (R.E. Marti, K.H. Bleicher, K.W. Bair).
-
Novartis Pharma
-
-
-
11
-
-
0040005059
-
-
ent-5-ent-7 and the Boc-protected derivatives have been previously described by us [3]
-
ent-5-ent-7 and the Boc-protected derivatives have been previously described by us [3].
-
-
-
-
12
-
-
0024359592
-
-
K. Barlos, D. Gatos, J. Kallitsis, G. Papaphotiu, P. Sotiriu, Y. Wenging, W. Schäfer, Tetrahedron Lett. 1989, 30, 3943.
-
(1989)
Tetrahedron Lett.
, vol.30
, pp. 3943
-
-
Barlos, K.1
Gatos, D.2
Kallitsis, J.3
Papaphotiu, G.4
Sotiriu, P.5
Wenging, Y.6
Schäfer, W.7
-
14
-
-
0041192368
-
-
ibid
-
R.B. Merrifield, Angew. Chem. 1985, 97, 801; ibid. Int. Ed. 1985, 24, 799.
-
(1985)
Int. Ed.
, vol.24
, pp. 799
-
-
-
16
-
-
0014772602
-
-
E. Kaiser, R.L. Colescott, C.D. Bossinger, P.I. Cook, Anal. Biochem. 1970, 34, 595.
-
(1970)
Anal. Biochem.
, vol.34
, pp. 595
-
-
Kaiser, E.1
Colescott, R.L.2
Bossinger, C.D.3
Cook, P.I.4
|